Skip to main content
. 2016 Feb 10;7(1):87–97. doi: 10.5306/wjco.v7.i1.87

Table 1.

The different types of the above mentioned drugs according to their vesicant potential

Neutrals Inflammitants Irritants Exfoliants (may have low vesicant potential) Vesicants
Asparaginase Bevacizumab bleomycin Bortezomib cetuximab, Cyclophosphamide Bortezomib Bendamustine Aclacinomycin cisplatin Docetaxel liposomal Doxorubicin mitoxantrone Oxaliplatin paclitaxel Actinomycin D
Cytarabine eribulin Fludarabine gemcitabine Ifosfamide 5-Fluorouracil methotrexate raltitrexed Bleomycin Dactinomycin daunorubicin Doxorubicin epirubicin Idarubicin mitomycin C Vinblastine vindesine
Melphalan rituximab Carboplatin dexrasoxane Vincristine vinorelbine
Trastuzumab Etoposide
Teniposide
Topotecan